Pfizer Medical @PfizerMed

Communicating emerging, trusted scientific information to healthcare professionals (HCPs). Pfizer sponsored, intended for U.S. HCPs. https://t.co/s5bPfuTvDc pfizermedical.pfizerpro.com USA Joined January 2022

Tweets

835
Followers

7K
Following

0
Likes

0

Pfizer Medical @PfizerMed

2 days ago

We are pleased to announce that the @US_FDA has now approved our gene therapy for the treatment of hemophilia B! #PfizerMedical Affairs For more information, click these links on.pfizer.com/3w9qSGW, on.pfizer.com/3waI8eS, and on.pfizer.com/3Whrdlv

0 0 1 179 0

Download Video

Pfizer Medical @PfizerMed

4 days ago

During #NationalMinorityHealthMonth, Pfizer is striving to improve awareness of #migraine disparities in minority groups. Please consider sharing with your HCP peers. #HealthEquity #InclusionMatters

0 1 1 134 0

Download Image

Pfizer Medical @PfizerMed

4 days ago

We are pleased to announce that the @US_FDA has now approved our gene therapy for the treatment of hemophilia B! #PfizerMedical Affairs For more information, click these links on.pfizer.com/3Qk3lK9, on.pfizer.com/44fCXqO, and on.pfizer.com/3JEtDTT

0 3 4 2K 1

Download Video

Pfizer Medical @PfizerMed

5 days ago

Introducing JANUS, a new subgroup data visualization tool. Designed for educational purposes, JANUS provides efficacy and safety outcomes of a JAK inhibitor in RA clinical trials. #JANUS #DataVisualization #RheumatoidArthritis

0 0 0 130 1

Pfizer Medical @PfizerMed

7 days ago

Did you know that healthcare disparities exist in #migraine, affecting underrepresented ethnic groups? During #NationalMinorityHealthMonth, Pfizer is working to raise awareness of these disparities. Please consider sharing with your HCP peers. #HealthEquity #InclusionMatters

0 0 2 206 1

Download Image

Pfizer Medical @PfizerMed

7 days ago

Learn about the results of a subgroup analysis of Chinese patients in a phase 3 clinical trial of an oral CGRP receptor antagonist for the acute treatment of #migraine. These findings were published in The Journal of Headache and Pain; click the image to learn more. #neurotwitter

0 0 0 145 0

Pfizer Medical @PfizerMed

a week ago

Just wrapped up an amazing congress at #AAN2024! Here are some of the incredible posters and presentations you might have missed #AANAM #NeuroTwitter

0 0 0 184 0

Pfizer Medical @PfizerMed

2 weeks ago

Join us for the final day of #AAN2024. Explore posters on the impact of a CGRP receptor antagonist on select analgesic use, potential drug interactions with a CGRP receptor antagonist, and pain severity assessment over a 48-hour period. #NeuroTwitter #AANAM

0 1 1 220 0

Pfizer Medical @PfizerMed

2 weeks ago

Pfizer will be presenting at the upcoming #AMCP2024 Annual Meeting on April 17th in New Orleans! We look forward to connecting with healthcare professionals and sharing our new research in #migraine.

0 0 0 184 0

Download Video

Pfizer Medical @PfizerMed

2 weeks ago

Don't miss Day 4 at #AAN2024! Explore #migraine and #womenshealth posters. Discover the prevalence and characteristics of women with menstrual migraine and the efficacy and safety of a CGRP receptor antagonist for acute treatment. Join us! #NeuroTwitter #AANAM

0 0 0 192 0

Pfizer Medical @PfizerMed

2 weeks ago

Pfizer is leading the way at #AMCP2024 with insightful posters on Endometriosis and Uterine Fibroids. Join us on April 17th for a deep dive into women's health. #WomensHealth #Endometriosis #UterineFibroids

0 0 0 198 0

Download Video

Pfizer Medical @PfizerMed

2 weeks ago

This week, in @JCC_IBD, data in patients with isolated #proctitis enrolled in the Phase 3 ELEVATE #UC clinical program with our once-daily, oral sphingosine 1-phosphate (S1P) receptor modulator were published. #ulcerativecolitis #PfizerMedical

0 0 1 174 0

Pfizer Medical @PfizerMed

2 weeks ago

Are you aware of the consequences of uncontrolled surgical bleeding in ambulatory surgery centers? Stay informed about the implications and explore potential solutions. Click here to learn more. #BleedingManagement #ASCs

0 0 0 133 0

Pfizer Medical @PfizerMed

2 weeks ago

Podcast Series Continued: Listen to the 3rd release of our Podcast Series: Clinical conversations between two experts about #AlopeciaAreata (AA), as two thought leaders discuss common misperceptions and facts about this disease state.

0 0 0 146 0

Pfizer Medical @PfizerMed

2 weeks ago

Come and be a part of Day 2 at #AAN2024! Gain valuable insights into the latest findings on acute medication overuse in individuals with #migraine. Don't miss out! Learn more at pfi.sr/TZ7 #NeuroTwitter #AANAM

0 0 1 258 0

Download Video

Pfizer Medical @PfizerMed

3 weeks ago

New research published in Arthritis & Rheumatology highlights the importance of assessing VTE risk factors when considering initiation of a JAK inhibitor or TNFi in patients with active rheumatoid arthritis (RA). #RheumatoidArthritis

0 0 1 150 0

Pfizer Medical @PfizerMed

3 weeks ago

Pfizer is announcing an Independent Medical Education Competitive Grant Program on Advances in #Migraine Management. Seeking grant applications to improve care, management, and outcomes of adult patients with migraine. Deadline: May 30. More info: on.pfizer.com/3PZHnw6 #MedEd

0 0 0 136 0

Pfizer Medical @PfizerMed

3 weeks ago

Announcing Pfizer’s #Headache Medicine Fellowship Competitive Grant Program. It’s our intent to support programs that prioritize diversity, equity, and inclusion, and value clinical practice, research, and education. Apply by May 14. #medicalfellowship

0 0 0 189 0

Pfizer Medical @PfizerMed

3 weeks ago

Pfizer will be attending the upcoming #AAN2024 Annual Meeting: April 13-18 in Denver! We look forward to connecting with healthcare professionals from around the world. Stay tuned for updates on our presentations. on.pfizer.com/4czU8Hk #NeuroTwitter #AANAM

0 0 1 232 1

Download Video

Pfizer Medical @PfizerMed

3 weeks ago

To enhance the global scientific community’s understanding of Lyme disease, together with @valnevaSE, we will be presenting research at 5 international conferences: NordTick, @CPHA_ACSP, @ESCMID, @ESPIDsociety, @vaccinenation If you’re attending, watch out for our presentations!